Resistin: A newly identified chemokine for human CD4-positive lymphocytes

Cardiovascular Research

Volumn 85, Issue 1, 2010, Pages 167-174

  Walcher, Daniel ^a   Hess, Katharina ^a   Berger, Rebecca ^a   Aleksic, Milos ^a   Heinz, Philipp ^a   Bach, Helga ^a   Durst, Renate ^a   Hausauer, Angelina ^a   Hombach, Vinzenz ^a   Marx, Nikolaus ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Atherosclerosis; CD4 positive lymphocytes; Migration; Resistin; Signalling

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; LIM KINASE; MYOSIN LIGHT CHAIN; P21 ACTIVATED KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN CDC42; PROTEIN TYROSINE KINASE; RAC1 PROTEIN; RESISTIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA;

ARTICLE; ATHEROGENESIS; CD4+ T LYMPHOCYTE; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOCYTE MIGRATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CD4-POSITIVE T-LYMPHOCYTES; CDC42 GTP-BINDING PROTEIN; CELL MOVEMENT; CHEMOKINES; GTP-BINDING PROTEINS; HUMANS; LIM KINASES; MYOSIN LIGHT CHAINS; P21-ACTIVATED KINASES; PHOSPHORYLATION; RAC1 GTP-BINDING PROTEIN; RESISTIN; RHOA GTP-BINDING PROTEIN; SRC-FAMILY KINASES;

EID: 72049113630     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp278     Document Type: Article

References (25)

1. Jung HS, Park KH, Cho YM, Chung SS, Cho HJ, Cho SY et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 2006;69:76-85.
2. Yang RZ, Huang Q, Xu A, McLenithan JC, Eisen JA, Shuldiner AR et al. Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun 2003;310:927-935.
3. Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 2001;285:561-564.
4. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV et al. Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001;50:2199-2202.
5. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307-312.
6. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW et al. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 2004;114: 232-239.
7. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003;108:736-740.
8. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 2004;314:415-419.
9. Calabro P, Samudio I, Willerson JT, Yeh ET. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 2004;110:3335-3340.
10. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
11. Hansson GK, Hellstrand M, Rymo L, Rubbia L, Gabbiani G. Interferongamma inhibits both proliferation and expression of differentiationspecificalpha- smooth muscle actin in arterial smooth muscle cells. J Exp Med 1989;170:1595-1608.
12. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135-1143.
13. Marx N, Kehrle B, Kohlhammer K, Grub M, Koenig W, Hombach V et al. PPAR acti-vatorsasantiinflammatory mediatorsinhumanT lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ Res 2002;90:703-710.
14. Martinet Y, Martinet N, Vignaud JM, Plenat F. Blood monocyte chemotaxis. J Immunol Methods 1994;174:209-214.
15. Stahle M, Veit C, Bachfischer U, Schierling K, Skripczynski B, Hall A et al. Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK. J Cell Sci 2003;116:3835-3846.
16. Kukhtina NB, Arefieva TI, Krasnikova TL. Intracellular signal cascade in CD4+ T-lymphocyte migration stimulated by interferon-gamma-inducible protein-10. Biochemistry 2005;70:652-656.
17. Zheng Y, Quilliam LA. Activation of the Ras superfamily of small GTPases. Workshop on exchange factors. EMBO Rep 2003;4:463-468.
18. Bokoch GM. Biology of the p21-activated kinases. Annu Rev Biochem 2003;72: 743-781.
19. Chong C, Tan L, Lim L, Manser E. The mechanism of PAK activation. Autopho-sphorylation events in both regulatory and kinase domains control activity. J Biol Chem 2001;276:17347-17353.
20. Edwards DC, Sanders LC, Bokoch GM, Gill GN. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol 1999;1:253-259.
21. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003;4:446-456.
22. Alblas J, Ulfman L, Hordijk P, Koenderman L. Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes. Mol Biol Cell 2001;12: 2137-2145.
23. Takata Y, Osawa H, Kurata M, Kurokawa M, Yamauchi J, Ochi M et al. Hyperre-sistinemia is associated with coexistence of hypertension and type 2 diabetes. Hypertension 2008;51:534-539.
24. Osawa H, Ochi M, Tabara Y, Kato K, Yamauchi J, Takata Y et al. Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes. Clin Endocrinol 2008;69:74-80.
25. Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endo-crinol 2007;156:279-284.